{"database": "lobbying", "table": "lobbying_activities", "rows": [[2867469, "75faa1ce-d8be-4ffd-8b6a-af6c5e591ac2", "Q3", "FORBES-TATE", 400976792, "NOVARTIS, INC.", 2022, "third_quarter", "CPT", "Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2022-10-17T11:21:29-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2867469"], "units": {}, "query_ms": 14.042387949302793, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}